Free Trial

Align Technology, Inc. $ALGN Shares Newly Acquired by Intech Investment Management LLC

Align Technology logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Intech Investment Management opened a new position in Align Technology, buying 133,541 shares worth about $17.7 million, or roughly 0.19% of the company. Several other institutional investors also increased their holdings; institutions and hedge funds own 88.43% of the stock.
  • Align reported quarterly EPS of $2.80, slightly above the $2.77 consensus, on revenue of $1.01 billion. Revenue rose 1.9% year over year.
  • Analysts hold a Moderate Buy consensus rating, with an average price target of $193.08; recent target cuts and rating changes included both Buy/Outperform and Hold/In-Line recommendations.
  • Interested in Align Technology? Here are five stocks we like better.

Intech Investment Management LLC purchased a new position in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 133,541 shares of the medical equipment provider's stock, valued at approximately $17,697,000. Intech Investment Management LLC owned about 0.19% of Align Technology at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in ALGN. Bessemer Group Inc. increased its position in Align Technology by 22,889.3% in the 3rd quarter. Bessemer Group Inc. now owns 75,175 shares of the medical equipment provider's stock valued at $9,953,000 after acquiring an additional 74,848 shares during the period. Hantz Financial Services Inc. lifted its holdings in shares of Align Technology by 3,126.1% during the third quarter. Hantz Financial Services Inc. now owns 60,941 shares of the medical equipment provider's stock worth $8,080,000 after purchasing an additional 59,052 shares during the period. Harbour Investments Inc. lifted its holdings in shares of Align Technology by 12,103.3% during the third quarter. Harbour Investments Inc. now owns 14,766 shares of the medical equipment provider's stock worth $1,955,000 after purchasing an additional 14,645 shares during the period. IFG Advisory LLC lifted its holdings in shares of Align Technology by 55,170.0% during the third quarter. IFG Advisory LLC now owns 11,054 shares of the medical equipment provider's stock worth $1,463,000 after purchasing an additional 11,034 shares during the period. Finally, AlTi Global Inc. bought a new stake in shares of Align Technology in the third quarter worth $540,000. Institutional investors and hedge funds own 88.43% of the company's stock.

Align Technology Price Performance

Shares of NASDAQ ALGN opened at $168.32 on Monday. Align Technology, Inc. has a twelve month low of $130.23 and a twelve month high of $200.43. The firm has a fifty day simple moving average of $151.67 and a 200 day simple moving average of $168.57. The company has a market capitalization of $11.86 billion, a PE ratio of 24.50, a P/E/G ratio of 2.18 and a beta of 1.74.

Align Technology (NASDAQ:ALGN - Get Free Report) last issued its quarterly earnings results on Wednesday, October 28th. The medical equipment provider reported $2.80 EPS for the quarter, beating analysts' consensus estimates of $2.77 by $0.03. The business had revenue of $1.01 billion for the quarter, compared to analysts' expectations of $1 billion. Align Technology had a net margin of 11.83% and a return on equity of 15.96%. The business's quarterly revenue was up 1.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.61 earnings per share. As a group, equities analysts expect that Align Technology, Inc. will post 9.21 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

ALGN has been the subject of a number of recent research reports. Raymond James Financial restated a "buy" rating on shares of Align Technology in a report on Monday, October 5th. Piper Sandler cut their target price on Align Technology from $235.00 to $205.00 and set an "overweight" rating on the stock in a report on Wednesday, October 21st. Evercore downgraded Align Technology from an "outperform" rating to an "in-line" rating and set a $155.00 target price on the stock. in a report on Monday, October 5th. Mizuho reduced their price target on Align Technology from $220.00 to $200.00 and set an "outperform" rating on the stock in a research report on Thursday, October 22nd. Finally, UBS Group reissued a "neutral" rating and issued a $189.00 price target on shares of Align Technology in a research note on Thursday, July 23rd. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $193.08.

Check Out Our Latest Stock Analysis on Align Technology

Align Technology Company Profile

(Free Report)

Align Technology, Inc. develops, manufactures and markets digital orthodontic and restorative dentistry products. Its best-known offering is the Invisalign system, which uses a series of custom-made clear aligners to straighten teeth. The company also sells Vivera retainers and iTero intraoral scanners, which support digital dental imaging and treatment planning. Founded in 1997, Align helped popularize clear-aligner orthodontic treatment as an alternative to traditional braces. Its digital dentistry portfolio also includes exocad software, used by dental professionals and laboratories to design dental restorations.

Featured Stories

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Align Technology Right Now?

Before you consider Align Technology, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Align Technology wasn't on the list.

While Align Technology currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines